These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 15720536)

  • 1. Impact of interferon-alpha therapy on liver fibrosis progression in patients with HBeAg-negative chronic hepatitis B.
    Papatheodoridis GV; Petraki K; Cholongitas E; Kanta E; Ketikoglou I; Manesis EK
    J Viral Hepat; 2005 Mar; 12(2):199-206. PubMed ID: 15720536
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long-term follow-up of alpha-interferon treatment of patients with chronic hepatitis B.
    van Zonneveld M; Honkoop P; Hansen BE; Niesters HG; Darwish Murad S; de Man RA; Schalm SW; Janssen HL
    Hepatology; 2004 Mar; 39(3):804-10. PubMed ID: 14999700
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-term suppression of hepatitis B e antigen-negative chronic hepatitis B by 24-month interferon therapy.
    Lampertico P; Del Ninno E; Viganò M; Romeo R; Donato MF; Sablon E; Morabito A; Colombo M
    Hepatology; 2003 Apr; 37(4):756-63. PubMed ID: 12668967
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of antiviral therapy on the immunohistochemical expression of bcl-xL and bax protein in patients with HBeAg-negative chronic hepatitis B.
    Cholongitas E; Papatheodoridis GV; Manesis EK; Petraki K; Tiniakos D; Hadziyannis SJ
    J Med Virol; 2011 Jul; 83(7):1165-71. PubMed ID: 21567420
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term lamivudine treatment achieves regression of advanced liver fibrosis/cirrhosis in patients with chronic hepatitis B.
    Xu B; Lin L; Xu G; Zhuang Y; Guo Q; Liu Y; Wang H; Zhou X; Wu S; Bao S; Cai W; Xie Q
    J Gastroenterol Hepatol; 2015 Feb; 30(2):372-8. PubMed ID: 25167956
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pilot study of combination therapy with ribavirin and interferon alfa for the retreatment of chronic hepatitis B e antibody-positive patients.
    Cotonat T; Quiroga JA; López-Alcorocho JM; Clouet R; Pardo M; Manzarbeitia F; Carreño V
    Hepatology; 2000 Feb; 31(2):502-6. PubMed ID: 10655277
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Peginterferon alpha-2b is safe and effective in HBeAg-positive chronic hepatitis B patients with advanced fibrosis.
    Buster EH; Hansen BE; Buti M; Delwaide J; Niederau C; Michielsen PP; Flisiak R; Zondervan PE; Schalm SW; Janssen HL;
    Hepatology; 2007 Aug; 46(2):388-94. PubMed ID: 17604363
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An assessment of serum leptin levels in patients with chronic viral hepatitis: a prospective study.
    Manolakopoulos S; Bethanis S; Liapi C; Stripeli F; Sklavos P; Margeli A; Christidou A; Katsanika A; Vogiatzakis E; Tzourmakliotis D; Theocharis S
    BMC Gastroenterol; 2007 May; 7():17. PubMed ID: 17540037
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Outcome of hepatitis B e antigen-negative chronic hepatitis B on long-term nucleos(t)ide analog therapy starting with lamivudine.
    Papatheodoridis GV; Dimou E; Dimakopoulos K; Manolakopoulos S; Rapti I; Kitis G; Tzourmakliotis D; Manesis E; Hadziyannis SJ
    Hepatology; 2005 Jul; 42(1):121-9. PubMed ID: 15962291
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Factors related to chronic hepatitis B relapse after interferon-alpha treatment: a follow-up study].
    Liu DL; Luo KX; Feng XR; Fu QX; Hou JL
    Nan Fang Yi Ke Da Xue Xue Bao; 2007 Aug; 27(8):1264-6, 1270. PubMed ID: 17715044
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-term entecavir therapy results in the reversal of fibrosis/cirrhosis and continued histological improvement in patients with chronic hepatitis B.
    Chang TT; Liaw YF; Wu SS; Schiff E; Han KH; Lai CL; Safadi R; Lee SS; Halota W; Goodman Z; Chi YC; Zhang H; Hindes R; Iloeje U; Beebe S; Kreter B
    Hepatology; 2010 Sep; 52(3):886-93. PubMed ID: 20683932
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Retreatment of chronic hepatitis B e antigen-positive patients with recombinant interferon alfa-2a. The European Concerted Action on Viral Hepatitis (EUROHEP).
    Carreño V; Marcellin P; Hadziyannis S; Salmerón J; Diago M; Kitis GE; Vafiadis I; Schalm SW; Zahm F; Manzarbeitia F; Jiménez FJ; Quiroga JA
    Hepatology; 1999 Jul; 30(1):277-82. PubMed ID: 10385667
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Outcome of anti-HBe positive chronic hepatitis B in alpha-interferon treated and untreated patients: a long term cohort study.
    Brunetto MR; Oliveri F; Coco B; Leandro G; Colombatto P; Gorin JM; Bonino F
    J Hepatol; 2002 Feb; 36(2):263-70. PubMed ID: 11830339
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The long-term outcome of interferon-alpha treated and untreated patients with HBeAg-negative chronic hepatitis B.
    Papatheodoridis GV; Manesis E; Hadziyannis SJ
    J Hepatol; 2001 Feb; 34(2):306-13. PubMed ID: 11281561
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Use of quantitative assays for hepatitis B e antigen and IgM antibody to hepatitis B core antigen to monitor therapy in chronic hepatitis B.
    Hayashi PH; Beames MP; Kuhns MC; Hoofnagle JH; Di Bisceglie AM
    Am J Gastroenterol; 1996 Nov; 91(11):2323-8. PubMed ID: 8931411
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serum adipokine levels in chronic liver diseases: association of resistin levels with fibrosis severity.
    Tsochatzis E; Papatheodoridis GV; Hadziyannis E; Georgiou A; Kafiri G; Tiniakos DG; Manesis EK; Archimandritis AJ
    Scand J Gastroenterol; 2008; 43(9):1128-36. PubMed ID: 18609175
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lamivudine vs lamivudine and interferon combination treatment of HBeAg(-) chronic hepatitis B.
    Yurdaydin C; Bozkaya H; Cetinkaya H; Sahin T; Karaoğuz D; Törüner M; Erkan O; Heper AO; Erden E; Bozdayi AM; Uzunalimoğlu O
    J Viral Hepat; 2005 May; 12(3):262-8. PubMed ID: 15850466
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Study of the relapse of patients with chronic hepatitis B undergoing first and repeated recombinant interferon-alpha therapy during long-term follow up].
    Liu DL; Luo KX; Feng XR; Fu QX; Hou JL
    Zhonghua Yi Xue Za Zhi; 2007 Jul; 87(26):1840-3. PubMed ID: 17922996
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic analysis in chronic hepatitis B patients: a retrospective study of 216 cases about Scheuer scores, in situ expression of viral antigens and tissue hepatitis B virus DNA levels.
    Zhu R; Huang H; Zhang H; Wang Z; Hu X; Zhai W; Lin Y; Wang J; Zhu H
    Liver Int; 2006 Feb; 26(1):82-9. PubMed ID: 16420513
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [A prospective study on histological and serological changes after interferon alpha-2b treatment in patients with chronic hepatitis B infection].
    Lang Z; Zhao C; Xu D
    Zhonghua Gan Zang Bing Za Zhi; 2001 Jun; 9(3):145-7. PubMed ID: 11517899
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.